1. Home
  2. PANL vs FULC Comparison

PANL vs FULC Comparison

Compare PANL & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pangaea Logistics Solutions Ltd.

PANL

Pangaea Logistics Solutions Ltd.

HOLD

Current Price

$7.17

Market Cap

476.2M

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$7.82

Market Cap

535.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PANL
FULC
Founded
1996
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
476.2M
535.5M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
PANL
FULC
Price
$7.17
$7.82
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$9.00
$16.38
AVG Volume (30 Days)
437.7K
871.0K
Earning Date
05-11-2026
04-27-2026
Dividend Yield
2.76%
N/A
EPS Growth
N/A
N/A
EPS
0.30
N/A
Revenue
$385,088,209.00
N/A
Revenue This Year
$0.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.94
$3.45
52 Week High
$9.39
$15.74

Technical Indicators

Market Signals
Indicator
PANL
FULC
Relative Strength Index (RSI) 42.83 50.67
Support Level $6.59 $7.40
Resistance Level $7.35 $8.20
Average True Range (ATR) 0.23 0.44
MACD 0.00 0.06
Stochastic Oscillator 11.31 54.08

Price Performance

Historical Comparison
PANL
FULC

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries collectively, Pangaea or the Company, provide seaborne drybulk logistics and transportation services as well as terminal and stevedoring services. Pangaea utilizes its logistics expertise to service a broad base of industrial customers who require the transportation of a wide variety of dry bulk cargoes, including grains, coal, iron ore, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The Company's operating segments include the shipping segment: The Company's operating segments include the shipping segment and six terminal and stevedoring operating segments. The company operates in the USA, Germany, Canada, Singapore, the United Kingdom, and other countries, with maximum from the USA and others.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: